Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP624208.RA579emrYTH7Yfxngp0srkyI2L8hVvlXV6aicRb5tl4DU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP624208.RA579emrYTH7Yfxngp0srkyI2L8hVvlXV6aicRb5tl4DU130_assertion type Assertion NP624208.RA579emrYTH7Yfxngp0srkyI2L8hVvlXV6aicRb5tl4DU130_head.
- NP624208.RA579emrYTH7Yfxngp0srkyI2L8hVvlXV6aicRb5tl4DU130_assertion description "[The PI3K/AKT pathway is hyperactivated in prostate cancer but its effective therapeutic targeting has proven difficult.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP624208.RA579emrYTH7Yfxngp0srkyI2L8hVvlXV6aicRb5tl4DU130_provenance.
- NP624208.RA579emrYTH7Yfxngp0srkyI2L8hVvlXV6aicRb5tl4DU130_assertion evidence source_evidence_literature NP624208.RA579emrYTH7Yfxngp0srkyI2L8hVvlXV6aicRb5tl4DU130_provenance.
- NP624208.RA579emrYTH7Yfxngp0srkyI2L8hVvlXV6aicRb5tl4DU130_assertion SIO_000772 23585456 NP624208.RA579emrYTH7Yfxngp0srkyI2L8hVvlXV6aicRb5tl4DU130_provenance.
- NP624208.RA579emrYTH7Yfxngp0srkyI2L8hVvlXV6aicRb5tl4DU130_assertion wasDerivedFrom befree-20150227 NP624208.RA579emrYTH7Yfxngp0srkyI2L8hVvlXV6aicRb5tl4DU130_provenance.
- NP624208.RA579emrYTH7Yfxngp0srkyI2L8hVvlXV6aicRb5tl4DU130_assertion wasGeneratedBy ECO_0000203 NP624208.RA579emrYTH7Yfxngp0srkyI2L8hVvlXV6aicRb5tl4DU130_provenance.